HopeStage
Back to all studies
RecruitingNCT05437588

Blood biomarkers and treatment outcomes in adolescents with depression or suicidal thoughts

About this titleRead the official source — NCT05437588
Interventional studyAges 10–24United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 10 years to 24 years.

Listed locations
Birmingham and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
240
Sponsor
University of Alabama at Birmingham
Sponsor type
University
Study type
Other
Intervention type
Genetic
Locations
United States
Age range
From 10 Years to 24 Years
Official registry ID
NCT05437588
Official title
Show the full official title

Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents

Recruitment & locations

Currently recruiting

Birmingham · Huntsville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alabama at Birmingham, a university.

Who can participate?

Listed age limits: 10 years to 24 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies